Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

7.90
Delayed Data
As of 4:00pm ET
 +0.10 / +1.28%
Today’s Change
5.20
Today|||52-Week Range
10.00
+20.61%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close7.80
Today’s open7.70
Day’s range7.60 - 7.90
Volume12,445
Average volume (3 months)37,299
Market cap$177.6M
Dividend yield--
Data as of 4:00pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-52.78%
Earnings growth (next 5 years)+13.28%
Revenue growth (last year)+6.98%
P/E ratio--
Price/Sales4.53
Price/Book1.30

Competitors

 Today’s
change
Today’s
% change
CBMGCellular Biomedicine...-0.15-1.17%
OSIROsiris Therapeutics ...-0.01-0.20%
PFNXPfenex Inc-0.22-2.62%
RXDXIgnyta Inc-0.05-1.00%
Data as of 4:02pm ET, 01/19/2017

Financials

Next reporting dateFebruary 22, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$50.4M
Annual profit (last year)$6.7M
Net profit margin13.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ariel Katz
Chief Financial Officer &
Vice President
Oren Bryan
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts


Search for Jobs